Novamind Closes the Acquisition of Cedar Psychiatry, a Leading Psychedelic Therapy Organization in the U.S. Psychedelics Investing
Micron Waste Announces Filing of Amended and Restated Interim Financial Statements and MD&A for the Three Months Ended March 31, 2020 and 2019 Medical Device Investing
Perimeter Medical Imaging Announces Expansion of ATLAS AI Project with Installation of OTISTM for AI development at Leading Cancer Care Center, MD Anderson Emerging Technology Investing
GreenStar Biosciences Completes Acquisition of 100 Percent of Eleusian Biosciences Corp. and Appoints Jonathan Gilbert to Board of Directors and Maghsoud Dariani as Chief Science Officer Psychedelics Investing
ALRT Launches Prediabetes Solution Completing Most Comprehensive Diabetes Management System Available Today Medical Device Investing
GreenStar Biosciences Announces Filing of Third Provisional Patent Application by Eleusian Biosciences Psychedelics Investing
Cybin Corp. Announces Proposed Management Team and Board of Directors of the Resulting Issuer Psychedelics Investing
GreenStar Biosciences Signs Definitive Agreement to Acquire 100% of Eleusian Biosciences Corp. Psychedelics Investing
